References
- Accuracy of the references is the responsibility of the author.
- Morgan GJ, Harris ED. Non-giant cell temporal arteritis. Arthritis Rheum 1978: 21: 362–6
- Goodman BW. Temporal arteritis. Am J Med 1979: 67: 839–52
- Keltner JL. Giant-cell arteritis. Ophthalmology 1982: 89: 1101–10
- Reich KA, Giansiracusa DF, Strongwater SL. Neurologic manifestations of giant cell arteritis. Am J Med 1990: 89: 67–72
- Mehler MF, Rabinowich L. The clinical neuro-ophthalmologic spectrum of temporal arteritis. Am J Med 1988: 85: 839–42
- Spiera H. Giant cell arteritis and polymyalgia rheumatica. Hosp Pract 1990 Nov: 71–88
- Hunder GG. Giant cell (temporal) arteritis. Rheum Dis Clin North Am 1990: 16: 339–409
- Hunder GG. Polymyalgia rheumatica and temporal (giant cell) arteritis. In: Primer of the rheumatic diseases. Atlanta: Arthritis Foundation, 1988
- Wilske KR, Healey LA. Polymyalgia rheumatica and giant cell arteritis. Postgrad Med 1985: 77(8): 243–8
- Reinitz E, Aversa A. Long-term treatment of temporal arteritis with dapsone. Am J Med 1988: 85: 456–7
- Krall PL, Mazanec DJ, Wilke WS. Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. Cleve Clin J Med 1989: 56: 253–7
- Lundberg I, Hedfors E. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1990: 17: 1340–5
- Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988: 38: 352–9
- Rosenfeld SI, Kosmorsky GS, Klingele TG, et al. Treatment of temporal arteritis with ocular involvement. Am J Med 1986: 80: 143–5
- Beevers DG, Harpur JE, Turk AD. Giant cell arteritis: the need for prolonged treatment. J Chron Dis 1973: 26: 571–84
- Cohen DN. Temporal arteritis: improvement in visual prognosis and management with repeat biopsies. Trans Am Acad Opnthalmol Otolaryngol 1973: 77: 74–85
- Model DG. Reversal of blindness in temporal arteritis with methylprednisolone. Lancet 1978 Feb: 340
- Friedberg MG, Rapuano CJ. Artende ischemic neuropathy. In: Office and emergency room diagnosis of eye disease. Philadelphia: JB Lippincott, 1990: chap 11
- Kyle V, Hazelman BL. Stopping steroids in polymyalgia rheumatica and giant cell arteritis. BMJ 1990: 300: 344–5
- Slavin ML, Margolis AJ. Progressive anterior ischemic optic neuropathy due to giant cell arteritis despite high-dose intravenous steroids. Arch Ophthalmol 1988: 106: 1167
- The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972: 13: 694–8
- Haynes RC Jr, Murad F. Adrenocorti-cotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis. In: Gilman AG, Goodman LS, Rail TW, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985: 1459–89
- Fauchald P, Rynvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica: clinical biopsy findings. Ann Intern Med 1972: 77: 845–52